Thirdly, recent studies suggested that NKD1 could serve as an independent predicting biomarker for tumor responsiveness of neoadjuvant chemo-radiotherapy in rectal cancer [31, 32], and whether NKD1 can help direct chemotherapy of gliomas deserve further investigations. The gene discussed is NKD1; the disease is rectal cancer.